Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation

Catherine Godfrey; Michael C Thigpen; Keith W Crawford; Patrick Jean-Phillippe; Deenan Pillay; Deborah Persaud; Daniel R Kuritzkes; Mark Wainberg; Elliot Raizes; Joseph Fitzgibbon

doi:10.1093/infdis/jix137

Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation

J Infect Dis. 2017 Dec 1;216(suppl_9):S798-S800. doi: 10.1093/infdis/jix137.

Affiliations

¹ National Institute of Allergy and Infectious Diseases, National Institutes of Health.
² University College London, United Kingdom.
³ Johns Hopkins University.
⁴ Brigham and Women's Hospital.
⁵ McGill University, Canada.
⁶ Centers for Disease Control and Prevention.

No abstract available

Keywords: HIV; HIV drug resistance; antiretroviral; drug resistance; genotyping; human immunodeficiency virus; low/middle-income countries; virological failure.

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Anti-HIV Agents / pharmacology*
Anti-HIV Agents / therapeutic use
Antiretroviral Therapy, Highly Active
Drug Resistance, Viral*
Global Health
HIV / drug effects*
HIV Infections / drug therapy
HIV Infections / epidemiology*
HIV Infections / virology*
Humans
National Institute of Allergy and Infectious Diseases (U.S.)
Public Health Surveillance
Referral and Consultation
Research
United States

Substances

Anti-HIV Agents